Brief: Eikon Therapeutics Announces Fourth Quarter And Full Year 2025 Financial Results And Provides Clinical And Corporate Updates
30/03/2026 14:51
March 30 (Reuters) - Eikon Therapeutics Inc EIKN.O: EIKON THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CLINICAL AND CORPORATE UPDATES Source text: ID:nGNX98bQc7 Further company coverage: EIKN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eikon Therapeutics
See all newsBrief: Eikon Therapeutics Appoints Johnny Bennett, Ph.D. To Its Scientific Advisory Board
Brief: Eikon Therapeutics Announces First Patient Dosed In Teluride-008, A Registrational Phase 2/3 Trial Of Eik1001 In Non-Small Cell Lung Cancer
Brief: Eikon Therapeutics Announces Fourth Quarter And Full Year 2025 Financial Results And Provides Clinical And Corporate Updates
Perlmutter-backed Eikon Therapeutics rises as IPO research quiet period ends
Merck veteran Perlmutter-led Eikon Therapeutics valued at $860 million in Nasdaq debut (updated)